Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Other Non Operating Income: 2021-2023

Historic Other Non Operating Income for Immuneering (IMRX) over the last 2 years, with Dec 2023 value amounting to $464,352.

  • Immuneering's Other Non Operating Income rose 107.97% to $464,352 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year increase of 515.32%. This contributed to the annual value of $1.3 million for FY2023, which is 515.31% up from last year.
  • According to the latest figures from Q4 2023, Immuneering's Other Non Operating Income is $464,352, which was down 2.36% from $475,595 recorded in Q3 2023.
  • In the past 5 years, Immuneering's Other Non Operating Income ranged from a high of $475,595 in Q3 2023 and a low of -$118,974 during Q4 2021.
  • In the last 3 years, Immuneering's Other Non Operating Income had a median value of $135,514 in 2022 and averaged $142,405.
  • Data for Immuneering's Other Non Operating Income shows a peak YoY spiked of 1,593.82% (in 2022) over the last 5 years.
  • Over the past 3 years, Immuneering's Other Non Operating Income (Quarterly) stood at -$118,974 in 2021, then surged by 287.67% to $223,278 in 2022, then skyrocketed by 107.97% to $464,352 in 2023.
  • Its last three reported values are $464,352 in Q4 2023, $475,595 for Q3 2023, and $150,193 during Q2 2023.